{blacktriangledown}Reboxetine - another new antidepressant

Drug and Therapeutics Bulletin 1998;36:86-88

${blacktriangledown}$ Reboxetine - another new antidepressant

Relevant BNF section: 4.3.4

${blacktriangledown}$ Reboxetine (Edronax - Pharmacia & Upjohn) is a new antidepressantdrug introduced last year for the acute treatment and, in patientswho respond, the maintenance treatment of depression. It ismarketed as a "new selective noradrenaline reuptake inhibitor"(or 'NARI'). The manufacturer claims that reboxetine "not onlylifts depressed mood" but also "helps restore social interaction",with "significantly better outcome in terms of social functioning"than fluoxetine. We assess these claims and consider the placeof reboxetine in therapy.